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The pancreas is extremely important in various enzymatic activities, such as the production of 
numerous enzymes such as insulin. Pancreatic Cancer is an extremely deadly disease, which 
40,000 people of the 46,000 diagnosed each year fail to survive. It is the 12th most common type 
of cancer and the 4th leading cause of cancer related deaths.  There are 4 stages to Pancreatic 
ranging from stage 1 to stage 4, where the cancer has spread to a distant organ. Pancreatic cancer 
is an extremely difficult to diagnose as early symptoms aren’t suggestive as many other illnesses 
have similar signs and symptoms. Diagnosis can be done through the use of physical 
examinations, ct scan, ultrasound, endoscopic ultrasound, PET scan, and most effectively a 
needle biopsy. Currently in development are numerous different therapies. A collective effort is 
being put forth to further improve current established methods to combat Pancreatic Cancer. A 
current four-drug chemotherapy, that had results published in May 2011 has shown a 4-month 
improvement using a regimen called Folfirinox. Compared to treatment with gemcitabine, which 
is the current therapy mainly utilized, Folfirinox showed improvement on 16 percent more 
patients in a phase 3 trial. Another trial with a combination of Nab-Paclitaxel and Gemcitabine 
was conducted against just gemcitabine. Patients with the combination showed a 1.8 months 
higher average survival rate than without, and showed a significantly higher survival rate through 
two years of 13% and 5% respectively. Overall these therapies must be reformed to be 
compatible with a bigger patient population. Subsequently the side effects of the treatments also 
need to be improved as the side effects include high risk of neutropenia.  Both these treatments 
demonstrate a more efficient therapy and have been implemented into practice but still require 
improvement.  
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